- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- panotherapeutics.com
- Last Round
- Venture Round
- Rounds
- 1
About
Pano Therapeutics is a San Francisco-based platform biotech company focused on the clinical development of patented small molecule drugs targeting mitochondrial ion channels. Founded in 2017 based on electrophysiology research at UCSF, the company's core discovery identified a novel mitochondrial ion channel associated with Metformin's mechanism of action. Pano is developing next-generation therapeutics for complex diseases of aging including Type 2 Diabetes, cancer, neurodegenerative disease, and cardiovascular disease, targeting indications where mitochondrial dysfunction is a key driver.
Summary
Pano Therapeutics is a Biotech company based in San Francisco, United States, founded in 2017. Investors include Western Technology Investment and Longevitytech.fund.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pano-therapeutics"><img src="https://indexed.vc/api/badge/company/pano-therapeutics" alt="Pano Therapeutics on Indexed.vc" width="260" height="76" /></a>